The recent discovery of novel PCA3 transcripts, inclusive of exons 2a and 2b, that are more highly enriched in PCa and metastases and the identification of complementary biomarkers [26,97] tantalises investigators who seek further improvements in PCa detection and characterisation through a non-invasive molecular approach. Here, PCA3 is linked to posterior cortical atrophy.